| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $5.07B+13.7% | $4.46B+7.3% | $4.15B+8.6% | $3.83B+34.6% | $2.84B |
| Cost of revenue | $2.59B+18.7% | $2.18B+3.3% | $2.11B+4.8% | $2.01B+38.7% | $1.45B |
| Gross profit | $2.48B+8.8% | $2.28B+11.5% | $2.04B+12.7% | $1.81B+30.4% | $1.39B |
| Research and development | $1.02B+1.1% | $1.01B+7.0% | $942.8M-12.6% | $1.08B+36.7% | $789.2M |
| Sales and marketing | $873.2M+1.4% | $860.8M-15.9% | $1.02B-18.0% | $1.25B+19.5% | $1.04B |
| General and administrative | $410.7M-8.6% | $449.1M-4.1% | $468.5M-9.5% | $517.4M+9.5% | $472.5M |
| Restructuring costs | $15.0M+13.2% | $13.3M-92.0% | $165.7M+116.3% | $76.6M | $0 |
| Impairment of long-lived assets | $1.8M | $0-100.0% | $320.5M+228.0% | $97.7M | $0 |
| Total operating expenses | $2.32B-0.5% | $2.33B-20.2% | $2.92B-3.3% | $3.02B+30.9% | $2.31B |
| Income (loss) from operations | $157.8M+393.8% | -$53.7M+93.9% | -$876.5M+27.3% | -$1.21B-31.6% | -$915.6M |
| Share of losses from equity method investment | -$101.2M+6.7% | -$108.5M+11.0% | -$121.9M-245.2% | -$35.3M | $0 |
| Impairment of equity method investment | -$80.6M | $0 | $0 | — | — |
| Impairment of strategic investments | $0+100.0% | -$8.2M+82.2% | -$46.2M | $0 | $0 |
| Other income, net | $79.1M-3.2% | $81.8M+70.9% | $47.9M+1690.7% | -$3.0M+93.4% | -$45.3M |
| Total other expenses, net | -$102.7M-194.3% | -$34.9M+71.0% | -$120.2M-213.6% | -$38.3M+15.5% | -$45.3M |
| Income (loss) before provision for income taxes | $55.1M+162.2% | -$88.6M+91.1% | -$996.7M+19.9% | -$1.24B-29.4% | -$960.9M |
| Provision for income taxes | -$21.3M-2.3% | -$20.8M-11.1% | -$18.7M-49.5% | -$12.5M-213.5% | $11.0M |
| Net income (loss) attributable to common stockholders | $33.8M+130.9% | -$109.4M+89.2% | -$1.02B+19.2% | -$1.26B-32.2% | -$949.9M |
| Basic (in dollars per share) | $220.00+133.3% | -$660.00+88.1% | -$5540.00+19.2% | -$6860.00-125771.6% | -$5.45 |
| Diluted (in dollars per share) | $210.00+131.8% | -$660.00+88.1% | -$5540.00+19.2% | -$6860.00-125771.6% | -$5.45 |
| Basic (in shares) | 152.99B-7.8% | 165.93B-9.5% | 183.33B+0.2% | 182.99B+104960.0% | 174.2M |
| Diluted (in shares) | 159.79B-3.7% | 165.93B-9.5% | 183.33B+0.2% | 182.99B+104960.0% | 174.2M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.